IIP
AGN

Intermede Investment Partners’s Allergan plc AGN Stock Holding History

Intermede Investment Partners’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-425,529
Closed -$62.3M – 26
2019
Q1 		$62.3M Buy
425,529
+51,349
+14% +$7.44M 3.87% 15
2018
Q4 		$50M Sell
374,180
-871
-0.2% -$143K 4% 13
2018
Q3 		$71.4M Buy
375,051
+137
+0% +$25.2K 5.35% 4
2018
Q2 		$62.5M Sell
374,914
-12,563
-3% -$2.02M 4.94% 6
2018
Q1 		$65.2M Sell
387,477
-23,083
-6% -$3.87M 5.6% 5
2017
Q4 		$67.2M Buy
410,560
+126,271
+44% +$22.7M 5.71% 4
2017
Q3 		$58.3M Buy
284,289
+28,374
+11% +$6.6M 5.33% 4
2017
Q2 		$62.2M Buy
255,915
+32,754
+15% +$7.7M 6.02% 2
2017
Q1 		$53.3M Buy
223,161
+15,732
+8% +$3.66M 5.57% 5
2016
Q4 		$43.6M Buy
207,429
+41,851
+25% +$8.67M 5.1% 4
2016
Q3 		$38.1M Buy
165,578
+2,048
+1% +$500K 4.22% 10
2016
Q2 		$37.8M Buy
+163,530
New +$37.7M 4.38% 9

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Intermede Investment Partners's AGN Position: Q2 2019 in Review

Intermede Investment Partners sold out of Allergan plc (AGN) in Q2 2019, closing a stake of 425,529 shares — an estimated $62.3M sold.

Intermede Investment Partners first reported a position in AGN in Q2 2016 and held it in 12 quarters. The position peaked at $71.4M in Q3 2018. 971 funds tracked by Wall St. Rank hold AGN as of Q2 2019.

  • Intermede Investment Partners reported no remaining Allergan plc position as of Q2 2019 after selling out during the quarter.
  • Intermede Investment Partners sold 425,529 Allergan plc shares in Q2 2019, an estimated $62.3M.
  • Intermede Investment Partners first reported a position in Allergan plc in Q2 2016 and held it in 12 quarters.
  • Intermede Investment Partners's Allergan plc position peaked at $71.4M in Q3 2018.
  • 971 funds tracked by Wall St. Rank held Allergan plc as of Q2 2019.

Based on Intermede Investment Partners's 13F filing for Q2 2019, filed 30 Jul 2019.